Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | RVMD | LEGN | ||
| Company | Reata Pharma | Revolution Medicines Inc | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 42.98 | 34.35 | ||
| High | 172.46 | 44.22 | 34.89 | ||
| Low | 172.32 | 42.53 | 33.76 | ||
| Last | 172.36 | 44.06 | 34.08 | ||
| Change | +0.04 | +0.77 | +0.06 | ||
| % Change | +0.02% | +1.78% | +0.18% | ||
| Volume | 1,988,500 | 2,673,600 | 1,644,200 | ||
| 20-Day Average Volume | 810,510 | 2,160,515 | 1,460,525 | ||
| Previous Close | 172.32 | 43.29 | 34.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 49.19 | 38.99 | ||
| 20-Day Raw Stochastic | 97.36% | 8.90% | 13.10% | ||
| 20-Day Relative Strength | 81.56% | 36.31% | 34.00% | ||
| Weighted Alpha | +177.60 | +44.40 | -48.09 | ||
| Today's Opinion | 100% Buy | 8% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -2.11% since 12/13/24 | -2.96% since 12/13/24 | ||
| Low | 171.96 on 09/19/23 | 42.53 on 12/20/24 | 32.50 on 12/19/24 | ||
| High | 172.46 on 09/25/23 | 46.15 on 12/16/24 | 35.37 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -22.80% since 11/20/24 | -15.10% since 11/20/24 | ||
| Low | 168.67 on 09/05/23 | 42.53 on 12/20/24 | 32.50 on 12/19/24 | ||
| High | 172.46 on 09/25/23 | 59.72 on 11/26/24 | 44.56 on 12/04/24 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -2.99% since 09/20/24 | -29.78% since 09/20/24 | ||
| Low | 88.80 on 06/27/23 | 42.53 on 12/20/24 | 32.50 on 12/19/24 | ||
| High | 172.46 on 09/25/23 | 62.40 on 11/11/24 | 51.77 on 10/15/24 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +17.37% since 06/20/24 | -16.47% since 06/20/24 | ||
| Low | 76.54 on 05/10/23 | 36.50 on 07/05/24 | 32.50 on 12/19/24 | ||
| High | 172.46 on 09/25/23 | 62.40 on 11/11/24 | 60.87 on 07/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 7,411,730 | 6,224,167 | ||
| Shares Outstanding, K | 38,150 | 168,219 | 182,634 | ||
| Annual Sales | 2,220,000 | 11,580,000 | 285,140,000 | ||
| Annual Net Income | -311,900,000 | -436,370,000 | -518,250,000 | ||
| Last Quarter Sales | 22,750,000 | 0 | 160,210,000 | ||
| Last Quarter Net Income | 193,000,000 | -156,290,000 | -125,320,000 | ||
| 60-Month Beta | 1.42 | 1.40 | 0.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | -0.94 on 11/06/24 | -0.34 on 11/12/24 | ||
| Latest Earnings Date | 11/14/23 | 11/06/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||